Journal profile · Pathology
Pathology & Oncology Research
ISSN 1219-4956 · eISSN 1532-2807 · Springer Netherlands · HUNGARY · Quarterly · Founded 1995
Pathology & Oncology Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.7; fully open access; APC about USD 2,500; median 92 days to acceptance (98 articles, last 24 months); community-reported acceptance: easy; 51 articles in 2025; indexed in SCIE and Scopus; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: Pathology & Oncology Research is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites. Source ↗Publisher website ·
Scope
Aims, scope and focus
Pathology & Oncology Research is published by Springer Netherlands and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, Cancer Genomics and Diagnostics and RNA modifications and cancer, together about 19.1% of its articles. Its main subfields are Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
As of 2021, Pathology & Oncology Research is now published by Frontiers. Please visit this link for more information – ...
From the journal's Aims & Scope
Research area (LetPub): Pathology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology7.5%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.9%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5.7%
- Genetic factors in colorectal cancerMedicine5.4%
- Sarcoma Diagnosis and TreatmentMedicine4.8%
- Cancer-related Molecular PathwaysMedicine4.8%
- Lymphoma Diagnosis and TreatmentMedicine4.4%
- Lung Cancer Treatments and MutationsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.7LetPub ·
- CiteScore 2026-06
- 5LetPub ·
- SJR 2026-06
- 0.74LetPub ·
- SNIP 2026-06
- 0.71LetPub ·
- h-index
- 44LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 1,772OpenAlex ·
- 2-year mean citedness
- 4.29OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 50LetPub ·
Articles by year OpenAlex count · 3,000 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 42 | 8 |
| 2025 | 51 | 51 | 161 |
| 2024 | 74 | 74 | 548 |
| 2023 | 104 | 104 | 709 |
| 2022 | 145 | 145 | 1,429 |
| 2021 | 165 | 165 | 2,208 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
92 daysMedian, submission to acceptance · P25–P75 61 days – 136 days
- Acceptance to online
- median 14 days (98 articles)
- Submission to online
- median 108 days
- Sample
- 98 articles with submission and acceptance dates (105 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Netherlands
- Country or region
- HUNGARY
- Language
- English
- Frequency
- Quarterly
- Founded
- 1995
- ISSN
- 1219-4956
- Electronic ISSN
- 1532-2807
- Society / sponsor
- Arányi Lajos Foundation
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Pathology & Oncology Research
What CAS zone is Pathology & Oncology Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pathology & Oncology Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pathology & Oncology Research?
The latest impact factor listed by LetPub is 2.7; CiteScore 5, h-index 76.
How long does peer review take at Pathology & Oncology Research?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 61–136 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Pathology & Oncology Research?
According to LetPub and DOAJ records, Pathology & Oncology Research is indexed in SCIE, Scopus and DOAJ.
Is Pathology & Oncology Research open access, and what is the APC?
Pathology & Oncology Research is a fully open-access journal. APC about USD 2,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .